Edmond DE Rothschild Holding S.A. Grows Stock Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

Edmond DE Rothschild Holding S.A. raised its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 636.3% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 5,890 shares of the financial services provider’s stock after acquiring an additional 5,090 shares during the period. Edmond DE Rothschild Holding S.A.’s holdings in iShares Biotechnology ETF were worth $779,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. HHM Wealth Advisors LLC increased its holdings in shares of iShares Biotechnology ETF by 200.0% in the fourth quarter. HHM Wealth Advisors LLC now owns 225 shares of the financial services provider’s stock valued at $30,000 after purchasing an additional 150 shares during the period. VSM Wealth Advisory LLC purchased a new position in iShares Biotechnology ETF in the 4th quarter valued at $30,000. Bradley & Co. Private Wealth Management LLC acquired a new position in iShares Biotechnology ETF in the 4th quarter valued at $32,000. Newbridge Financial Services Group Inc. purchased a new position in iShares Biotechnology ETF during the 4th quarter worth $33,000. Finally, Hager Investment Management Services LLC acquired a new stake in shares of iShares Biotechnology ETF in the 4th quarter worth $34,000. 62.45% of the stock is owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Stock Down 2.7 %

Shares of iShares Biotechnology ETF stock opened at $124.44 on Wednesday. The firm has a market cap of $5.88 billion, a price-to-earnings ratio of 27.83 and a beta of 0.84. iShares Biotechnology ETF has a 52-week low of $123.60 and a 52-week high of $150.57. The company’s 50-day simple moving average is $135.83 and its 200-day simple moving average is $138.58.

iShares Biotechnology ETF Increases Dividend

The firm also recently announced a dividend, which was paid on Friday, March 21st. Shareholders of record on Tuesday, March 18th were given a dividend of $0.1212 per share. This is a boost from iShares Biotechnology ETF’s previous dividend of $0.06. The ex-dividend date of this dividend was Tuesday, March 18th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.